Bracco Diagnostics' cardiac PET perfusion imaging agent CardioGen-82, a rubidium Rb 82 generator, is designed to help offer clear perfusion images within minutes.
The mVisum STEMI Alert System allows transmission of ECGs and other patient data directly to a physician's Blackberry to reduce the amount of time it takes for a diagnosis to help lower door-to-balloon time.
April 2, 2009 — With the Medicare and Medicaid incentives for health information technology use announced, almost 70 percent of U.S. hospitals are only two steps or less away from having the health IT applications necessary to deliver the likely objectives of ‘meaningful use’ for the electronic medical record, according to the HIMSS Analytics EMR Adoption Model (EMRAM).
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
The QuikClot Interventional dressing made by Z-Medica uses a mineral impregnated bandage to achieve hemostasis from femoral access site bleeding within three minutes. The pad comes with a Tegaderm transparent dressing to hold it in place.
April 2, 2009 - Volcano Corp. this week at ACC 2009 announced the availability of its integrated fractional flow reserve (FFR) technology on all major cardiovascular X-ray systems.
A trend in nuclear cardiac myocardial perfusion imaging in recent years has been toward smaller gamma cameras that can be easily be installed in outpatient offices, which Siemens highlighted at ACC 2009 with its c.cam SPECT system.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
April 2, 2008 – Siemens Healthcare has been awarded Frost & Sullivan’s 2009 North American Magnetic Resonance Imaging Scanners Market Leadership Award.

April 2, 2009 - A device implanted in the heart using minimally invasive techniques may replace the most widely prescribed drug for stroke prevention in patients with nonvalvular atrial fibrillation, according to research presented during the i2 Summit at the American College of Cardiology’s 58th annual scientific session in Orlando earlier this week.
April 2, 2009 - New findings from a landmark investigational study demonstrated that, for patients with atrial fibrillation who were at increased risk for stroke and could not take an oral anticoagulant (OAC) medication, taking Plavix (clopidogrel bisulfate) in addition to aspirin significantly reduced major vascular events by 11 percent over aspirin alone, at a median of 3.6 years of follow-up (6
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
April 2, 2009 - The American College of Cardiology Foundation (ACCF) and the Heart Rhythm Society (HRS) are collaborating to deliver free, unlimited access to Cardiosource’s Arrhythmias and Atrial Fibrillation (AF) Clinical Collections containing relevant, up-to-date information for cardiology professionals.
April 2, 2009 — Abbott yesterday announced the initiation of the MOBILITY clinical trial to study the safety and efficacy of the Absolute Pro Peripheral Self-Expanding Stent System in patients with iliac artery disease.
April 2, 2009 - Vasomedical Inc. this week conducted two presentations on the beneficial effects of EECP external counterpulsation therapy at the 58th Annual Scientific Session of the American College of Cardiology (ACC) in Orlando.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
April 2, 2009 - The 24-month findings from the REVERSE (Resynchronization Reverse Remodeling in Systolic Left Ventricular Dysfunction) trial, sponsored by Medtronic Inc.
April 2, 2009 - Researchers from the University of Massachusetts Memorial Medical Center's division of vascular and endovascular surgery, examined the national frequency, predictors, outcomes and the effect of institutional volume metrics in cases where endovascular aortic repair (EVAR) was used to repair ruptured abdominal aortic aneurysms (RAAAs) between 2001 and 2006.
April 2, 2009 - TCA Cellular Therapy’s Medical Director Gabriel Lasala, M.D. presented preliminary results of an adult stem cell treatment for severe limb ischemia Sunday at the American College of Cardiology’s first annual i2 Summit.